Food And Drug Administration-Amylin Pharmaceuticals-Healthday News-Bydureon

Bydureon Approved for Type 2 Diabetes

FRIDAY, Jan. 27 (Healthday News) -- Bydureon (exenatide extended release), Amylin Pharmaceuticals' long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food And Drug Administration. read more..

source:http://yhoo.it/yNcRWi